Show simple item record

dc.contributor.authorSwallow, Diane M A
dc.contributor.authorLawton, Michael A
dc.contributor.authorGrosset, Katherine A
dc.contributor.authorMalek, Naveed
dc.contributor.authorKlein, Johannes
dc.contributor.authorBaig, Fahd
dc.contributor.authorRuffmann, Claudio
dc.contributor.authorBajaj, Nin P
dc.contributor.authorBarker, Roger A
dc.contributor.authorBen-Shlomo, Yoav
dc.contributor.authorBurn, David J
dc.contributor.authorFoltynie, Thomas
dc.contributor.authorMorris, Huw R
dc.contributor.authorWilliams, Nigel
dc.contributor.authorWood, Nicholas W
dc.contributor.authorHu, Michele T M
dc.contributor.authorGrosset, Donald G
dc.date.accessioned2017-09-11T11:00:15Z
dc.date.available2017-09-11T11:00:15Z
dc.date.issued2016-11
dc.identifier.citationSwallow , D M A , Lawton , M A , Grosset , K A , Malek , N , Klein , J , Baig , F , Ruffmann , C , Bajaj , N P , Barker , R A , Ben-Shlomo , Y , Burn , D J , Foltynie , T , Morris , H R , Williams , N , Wood , N W , Hu , M T M & Grosset , D G 2016 , ' Statins are underused in recent-onset Parkinson's disease with increased vascular risk : findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts ' , Journal of Neurology, Neurosurgery & Psychiatry , vol. 87 , no. 11 , pp. 1183-1190 . https://doi.org/10.1136/jnnp-2016-313642en
dc.identifier.issn0022-3050
dc.identifier.otherPURE: 108134723
dc.identifier.otherPURE UUID: 1fab32cd-f786-4cbb-b528-3930f780cba8
dc.identifier.otherPubMed: 27671901
dc.identifier.otherPubMedCentral: PMC5116532
dc.identifier.otherScopus: 84988921991
dc.identifier.otherORCID: /0000-0002-0994-3561/work/36744906
dc.identifier.urihttp://hdl.handle.net/2164/9280
dc.descriptionPublished by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.en
dc.format.extent8
dc.language.isoeng
dc.relation.ispartofJournal of Neurology, Neurosurgery & Psychiatryen
dc.rightsCopyright information Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectAge Factorsen
dc.subjectAgeden
dc.subjectCardiovascular Diseasesen
dc.subjectComorbidityen
dc.subjectCross-Sectional Studiesen
dc.subjectDrug Utilizationen
dc.subjectEnglanden
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectHydroxymethylglutaryl-CoA Reductase Inhibitorsen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectParkinson Diseaseen
dc.subjectPhenotypeen
dc.subjectRisk Assessmenten
dc.subjectJournal Articleen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleStatins are underused in recent-onset Parkinson's disease with increased vascular risk : findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohortsen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1136/jnnp-2016-313642


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record